Is CHD Underperforming the Consumer Defensive Sector?

$ 22.2 billion, Church & Dwight Co. , Inc. (CHD) is a pioneering developer, manufacturer and marketer for home products, personal care and specialized products. The company’s portfolio, known as The US Leader, is famous for the production of sodium bicarbonate, for distinctive energy marks such as ARM & Hammeer, Trojan, OCICSLAN, Waterpik and Vitafussion.

Companies valued at more than $ 10 billion in general are “large” shares, and Church & Dwight fits this standard completely. It works in the sectors of local, international and specialized products, and Church & Dwight serves consumers worldwide through retail, e -commerce and industrial distribution channels.

The shares of Ewing, New Jersey, which is based in New Jersey, decreased by 21.7 % of its highest level in 52 weeks at 116.46 dollars. The CHD shares have decreased to more than 6 % over the past three months, lagging behind the SPDR SPDR (XLP) decreased by 1.9 % on the same time frame.

In the long run, the CHD share decreased by 12.9 % on the basis of YTD, which is XLP 1 %. Moreover, the shares of the home and personal products maker decreased by 12.3 % over 52 weeks, compared to the XLP decrease by 5.4 % on the same time frame.

Despite some fluctuations, the stock has been traded by average of 50 days and 200 days since April.

The Church & Dwight shares recovered marginally on the first of August, as the company achieved the results of the Q2 2025 that expected from expected, as the modified EPS amounted to $ 0.94 and revenues of $ 1.51 billion. The force in international sales of consumers and continuous momentum in e -commerce, which represents 23 % of consumer sales, has helped compensate for the smoothness in the local sector of the consumer.

In addition, Clorox Company (CLX) competition has significantly low -performance CHD shares. CLX shares fell by 24.4 % on the basis of YTD and 26.1 % over 52 weeks.

Although CHD doctors are weak for the sector, analysts are moderately optimistic about its horizons. The stock contains a consensus classification for “moderate purchase” of 22 analysts in coverage, and the average target price of $ 101.94 is a premium of 11.7 % to the current levels.

On the date of publication, Sohini Mondal did not have positions (either directly or indirectly) in any of the securities mentioned in this article. All information and data in this article are only for media purposes. This article was originally published on Barchart.com